Citadel Advisors
TECH icon

Citadel Advisors’s Bio-Techne TECH Stock Holding History

Citadel Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.67M Sell
52,000
-11,800
-18% -$637K ﹤0.01% 5277
2026
Q1 		$3.33M Sell
63,800
-6,500
-9% -$390K ﹤0.01% 5052
2025
Q4 		$4.13M Buy
70,300
+15,400
+28% +$936K ﹤0.01% 4587
2025
Q3 		$3.05M Buy
54,900
+16,700
+44% +$895K ﹤0.01% 5278
2025
Q2 		$1.97M Buy
38,200
+28,300
+286% +$1.42M ﹤0.01% 5734
2025
Q1 		$580K Buy
9,900
+2,000
+25% +$136K ﹤0.01% 8151
2024
Q4 		$569K Sell
7,900
-2,600
-25% -$191K ﹤0.01% 8276
2024
Q3 		$839K Buy
10,500
+900
+9% +$67.6K ﹤0.01% 7211
2024
Q2 		$688K Sell
9,600
-105,500
-92% -$7.76M ﹤0.01% 7390
2024
Q1 		$8.1M Sell
115,100
-2,600
-2% -$186K ﹤0.01% 3216
2023
Q4 		$9.08M Buy
117,700
+67,400
+134% +$4.44M ﹤0.01% 2981
2023
Q3 		$3.42M Buy
50,300
+43,000
+589% +$3.4M ﹤0.01% 4265
2023
Q2 		$596K Sell
7,300
-8,200
-53% -$659K ﹤0.01% 7553
2023
Q1 		$1.15M Sell
15,500
-8,700
-36% -$671K ﹤0.01% 6470
2022
Q4 		$2.01M Buy
24,200
+200
+0.8% +$15.9K ﹤0.01% 5487
2022
Q3 		$1.7M Buy
24,000
+9,600
+67% +$830K ﹤0.01% 5896
2022
Q2 		$1.25M Sell
14,400
-22,400
-61% -$2.1M ﹤0.01% 6516
2022
Q1 		$3.98M Sell
36,800
-10,400
-22% -$1.07M ﹤0.01% 4617
2021
Q4 		$6.11M Sell
47,200
-35,200
-43% -$4.32M ﹤0.01% 3945
2021
Q3 		$9.98M Sell
82,400
-5,600
-6% -$682K ﹤0.01% 3084
2021
Q2 		$9.91M Buy
88,000
+32,400
+58% +$3.41M ﹤0.01% 3092
2021
Q1 		$5.31M Buy
55,600
+38,800
+231% +$3.54M ﹤0.01% 4125
2020
Q4 		$1.33M Sell
16,800
-16,000
-49% -$1.16M ﹤0.01% 6181
2020
Q3 		$2.03M Buy
32,800
+11,600
+55% +$755K ﹤0.01% 4684
2020
Q2 		$1.4M Buy
+21,200
New +$1.27M ﹤0.01% 5205
2013
Q3 		– Sell
-5,600
Closed -$97K – 6863
2013
Q2 		$97K Buy
+5,600
New +$93K ﹤0.01% 5248

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Citadel Advisors's TECH Position: Q2 2026 in Review

Citadel Advisors increased its Bio-Techne (TECH) stake by 2,126% in Q2 2026, buying an estimated $49.8M and bringing the position to 965,918 shares worth $68.2M. The position accounts for 0.01% of the portfolio, ranked #1265.

Citadel Advisors first reported a position in TECH in Q2 2013 and has held it in 52 quarters since. The position peaked at $127M in Q2 2025. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Citadel Advisors held 965,918 shares of Bio-Techne worth $68.2M as of Q2 2026.
  • Citadel Advisors bought 922,516 Bio-Techne shares in Q2 2026, an estimated $49.8M.
  • Bio-Techne made up 0.01% of Citadel Advisors's portfolio in Q2 2026, its #1265 holding.
  • Citadel Advisors first reported a position in Bio-Techne in Q2 2013 and has held it in 52 quarters since.
  • Citadel Advisors's Bio-Techne position peaked at $127M in Q2 2025.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.